Epigenetics in ovarian cancer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Ovarian cancer is a disease with a poor prognosis and little progress has been made to improve treatment. It is now recognized that there are several histotypes of ovarian cancer, each with distinct epidemiologic and genomic characteristics. Cancer therapy is moving beyond classical chemotherapy to include epigenetic approaches. Epigenetics is the dynamic regulation of gene expression by DNA methylation and histone post translational modification in response to environmental cues. Improvement in technology to study DNA methylation has enabled a more agnostic approach and, with larger samples sets, has begun to unravel how epigenetics contributes to the etiology, response to chemotherapy and prognosis in of ovarian cancer. Investigations into histone modifications in ovarian cancer are more nascent. Much more is needed to be done to fully realize the potential that epigenetics holds for ovarian cancer clinical care.

Original languageEnglish (US)
JournalSeminars in Cancer Biology
DOIs
StateAccepted/In press - 2017

Fingerprint

Epigenomics
Ovarian Neoplasms
DNA Methylation
Histone Code
Drug Therapy
Gene Expression Regulation
Post Translational Protein Processing
Histones
Cues
Technology
Therapeutics
Neoplasms

Keywords

  • Chromatin
  • DNA methylation
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research

Cite this

Epigenetics in ovarian cancer. / Natanzon, Yanina; Goode, Ellen L; Cunningham, Julie M.

In: Seminars in Cancer Biology, 2017.

Research output: Contribution to journalArticle

@article{8a62b8dea540419083dc658fa797540c,
title = "Epigenetics in ovarian cancer",
abstract = "Ovarian cancer is a disease with a poor prognosis and little progress has been made to improve treatment. It is now recognized that there are several histotypes of ovarian cancer, each with distinct epidemiologic and genomic characteristics. Cancer therapy is moving beyond classical chemotherapy to include epigenetic approaches. Epigenetics is the dynamic regulation of gene expression by DNA methylation and histone post translational modification in response to environmental cues. Improvement in technology to study DNA methylation has enabled a more agnostic approach and, with larger samples sets, has begun to unravel how epigenetics contributes to the etiology, response to chemotherapy and prognosis in of ovarian cancer. Investigations into histone modifications in ovarian cancer are more nascent. Much more is needed to be done to fully realize the potential that epigenetics holds for ovarian cancer clinical care.",
keywords = "Chromatin, DNA methylation, Ovarian cancer",
author = "Yanina Natanzon and Goode, {Ellen L} and Cunningham, {Julie M}",
year = "2017",
doi = "10.1016/j.semcancer.2017.08.003",
language = "English (US)",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Epigenetics in ovarian cancer

AU - Natanzon, Yanina

AU - Goode, Ellen L

AU - Cunningham, Julie M

PY - 2017

Y1 - 2017

N2 - Ovarian cancer is a disease with a poor prognosis and little progress has been made to improve treatment. It is now recognized that there are several histotypes of ovarian cancer, each with distinct epidemiologic and genomic characteristics. Cancer therapy is moving beyond classical chemotherapy to include epigenetic approaches. Epigenetics is the dynamic regulation of gene expression by DNA methylation and histone post translational modification in response to environmental cues. Improvement in technology to study DNA methylation has enabled a more agnostic approach and, with larger samples sets, has begun to unravel how epigenetics contributes to the etiology, response to chemotherapy and prognosis in of ovarian cancer. Investigations into histone modifications in ovarian cancer are more nascent. Much more is needed to be done to fully realize the potential that epigenetics holds for ovarian cancer clinical care.

AB - Ovarian cancer is a disease with a poor prognosis and little progress has been made to improve treatment. It is now recognized that there are several histotypes of ovarian cancer, each with distinct epidemiologic and genomic characteristics. Cancer therapy is moving beyond classical chemotherapy to include epigenetic approaches. Epigenetics is the dynamic regulation of gene expression by DNA methylation and histone post translational modification in response to environmental cues. Improvement in technology to study DNA methylation has enabled a more agnostic approach and, with larger samples sets, has begun to unravel how epigenetics contributes to the etiology, response to chemotherapy and prognosis in of ovarian cancer. Investigations into histone modifications in ovarian cancer are more nascent. Much more is needed to be done to fully realize the potential that epigenetics holds for ovarian cancer clinical care.

KW - Chromatin

KW - DNA methylation

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85028365150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028365150&partnerID=8YFLogxK

U2 - 10.1016/j.semcancer.2017.08.003

DO - 10.1016/j.semcancer.2017.08.003

M3 - Article

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

ER -